De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Study Number: NRG-BR007
This Phase III Trial evaluates whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.
Radiation at OSF-Glen Oak, OSF-Rt 91, OSF Saint Joseph (Bloomington), Carle, and Western Illinois Cancer Treatment Center (Galesburg)
- Navigator Angie, 309-243-3613, email@example.com
- Kelsey, 309-243-3618 firstname.lastname@example.org